Nova In Silico

nova provides its jinkō clinical trials simulation platform to biotech and pharma companies, academic research centers and not-for-profit organizations. jinkō® unlocks the potential of modeling & simulation to de-risk and accelerate the r&d of new therapies for the benefit of patients: identify best responders, optimise the drug's regimen, generate synthetic control arms, explore research outcomes that might not be feasible with conventional trials. predict trial outcomes before advancing to real-world clinical trials and ultimately design studies that are more likely to succeed with jinkō®.